Actively Recruiting
Engage for Late-Life Depression and Comorbid Executive Dysfunction
Led by University of Nevada, Las Vegas · Updated on 2024-08-06
20
Participants Needed
1
Research Sites
83 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is a behavioral treatment approach that has shown to be effective in treating late life depression. The investigators are testing the feasibility of Engage as a treatment method for late life depression in older adults with cognitive decline. The objective is to corroborate Engage as an alternative late life depression treatment method for a sub-population of older adults with cognitive decline. Cognitive decline poses a unique mental health treatment barrier that is often over looked in younger populations. With a relatively higher prevalence of cognitive decline in older adulthood, it is imperative that a feasible mental health treatment program that can be effective in the presence of cognitive decline.
CONDITIONS
Official Title
Engage for Late-Life Depression and Comorbid Executive Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 or older
- Ability to read, write, and speak English
- Located in Las Vegas or surrounding area
- Ability to travel to UNLV campus by self or possible caregiver for regular study visits
- Clinically significant symptoms of depression as shown by scores greater than 5 on the Geriatric Depression Scale-Short Form (GDS-SF)
- Mild cognitive impairment shown by scores greater than 18 and less than 25 on the Montreal Cognitive Assessment (MoCA)
You will not qualify if you...
- Active suicidal ideation
- History of suicide attempt(s)
- Current symptoms of psychosis or active substance use disorder
- History of bipolar disorder (manic depression) or intellectual disability
- Currently in or scheduled to start individual psychotherapy to avoid treatment interference
- Psychotropic medication allowed if dose has been stable for past 2 weeks
- Currently living in an institutional setting (assisted living, inpatient, skilled nursing)
- Significant memory deficits shown by scores less than 9 on the MoCA memory subscale making it hard to participate in weekly psychotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Nevada
Las Vegas, Nevada, United States, 89154
Actively Recruiting
Research Team
B
Brenna R Renn, PhD
CONTACT
M
Matthew S Schurr, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here